跳至主要内容
临床试验/NCT07526935
NCT07526935进行中(未招募)不适用

Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator in the Management of Refractory Gastroparesis- A Randomized Single Blinded Control Trial

Baylor Research Institute1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年3月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
40
试验地点
1
主要终点
Gastroparesis Symptoms Changes

研究概览

简要总结

This study is looking at how safe and effective G-POEM, GES and a combination of both are for people with severe stomach problems (gastroparesis) that haven't gotten better with medicine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients of age 18 years and older
  • Patients must be able to consent
  • Documented diagnosis of refractory GP as determined by the following criteria:
  • Medically refractory GP symptoms for > 1 year despite treatment with first-line modalities and pharmacotherapies with anti-emetics and prokinetics AND
  • Gastric emptying scintigraphy showing delayed gastric emptying with retention of >60% at 2h and/or greater than 10% at 4h based on standardized radionuclide solid meal test
  • Preoperative Gastroparesis Cardinal Symptom Index (GCSI) Score
  • Aecision to treat patient with surgical therapy of G-POEM and/or electric stimulator

排除标准

  • Patients with prior surgical intervention for gastroparesis
  • Patients less than 18 years old
  • Pregnant women

研究组 & 干预措施

G-POEM only

Active Comparator

GES off + GPOEM

干预措施: G-POEM only (Procedure)

Control group

Active Comparator

GES off + Upper Endoscopy

干预措施: Standard of Care (Other)

GES only

Active Comparator

GES on + Upper Endoscopy

干预措施: Group 1 (Device)

Combination G-POEM and GES

Active Comparator

GES on + GPOEM

干预措施: Group 2 (Device)

结局指标

主要结局

Gastroparesis Symptoms Changes

时间窗: Baseline, Preoperative 3 months, 6 months, 9 months, 12 months

Monitoring changes in gastroparesis symptom severity as measured by the Gastroparesis Cardinal Symptom Index (GCSI).

次要结局

  • Subjects quality of life(Baseline, 6 months, 12 months.)
  • Weight(Baseline, 6 months, 12 months)
  • BMI(Baseline, 6 months, 12 months)
  • Nurtritional Support Status(Baseline, 6 months, 12 months)
  • Gastroparesis-related hospitalizations(12 month follow-up)
  • ED visits for symptoms(12 month follow-up)
  • Gastric Emptying(Baseline, 6 months, 12 months)
  • Antiemetic/Prokinetic use(Baseline, 6 months, 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验